JP2015505829A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015505829A5 JP2015505829A5 JP2014544867A JP2014544867A JP2015505829A5 JP 2015505829 A5 JP2015505829 A5 JP 2015505829A5 JP 2014544867 A JP2014544867 A JP 2014544867A JP 2014544867 A JP2014544867 A JP 2014544867A JP 2015505829 A5 JP2015505829 A5 JP 2015505829A5
- Authority
- JP
- Japan
- Prior art keywords
- tissue
- ischemia
- cells
- stem
- progenitor cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161566494P | 2011-12-02 | 2011-12-02 | |
| US61/566,494 | 2011-12-02 | ||
| PCT/US2012/066984 WO2013082241A2 (en) | 2011-12-02 | 2012-11-29 | Improved methods of treating ischemia |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017041708A Division JP6415616B2 (ja) | 2011-12-02 | 2017-03-06 | 虚血を処置する改善された方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015505829A JP2015505829A (ja) | 2015-02-26 |
| JP2015505829A5 true JP2015505829A5 (enExample) | 2016-01-28 |
| JP6106688B2 JP6106688B2 (ja) | 2017-04-05 |
Family
ID=48536234
Family Applications (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014544867A Active JP6106688B2 (ja) | 2011-12-02 | 2012-11-29 | 虚血を処置する改善された方法 |
| JP2017041708A Active JP6415616B2 (ja) | 2011-12-02 | 2017-03-06 | 虚血を処置する改善された方法 |
| JP2018153543A Active JP6727261B2 (ja) | 2011-12-02 | 2018-08-17 | 虚血を処置する改善された方法 |
| JP2020112693A Withdrawn JP2020158540A (ja) | 2011-12-02 | 2020-06-30 | 虚血を処置する改善された方法 |
| JP2022070033A Pending JP2022093428A (ja) | 2011-12-02 | 2022-04-21 | 虚血を処置する改善された方法 |
Family Applications After (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017041708A Active JP6415616B2 (ja) | 2011-12-02 | 2017-03-06 | 虚血を処置する改善された方法 |
| JP2018153543A Active JP6727261B2 (ja) | 2011-12-02 | 2018-08-17 | 虚血を処置する改善された方法 |
| JP2020112693A Withdrawn JP2020158540A (ja) | 2011-12-02 | 2020-06-30 | 虚血を処置する改善された方法 |
| JP2022070033A Pending JP2022093428A (ja) | 2011-12-02 | 2022-04-21 | 虚血を処置する改善された方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (3) | US10111907B2 (enExample) |
| EP (2) | EP2785350B1 (enExample) |
| JP (5) | JP6106688B2 (enExample) |
| ES (1) | ES2682255T3 (enExample) |
| WO (1) | WO2013082241A2 (enExample) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2785350B1 (en) * | 2011-12-02 | 2018-05-02 | Fate Therapeutics, Inc. | Improved methods of treating ischemia |
| CN104066837B (zh) | 2011-12-02 | 2020-12-08 | 菲特治疗公司 | 增强的干细胞组合物 |
| WO2014093531A1 (en) * | 2012-12-11 | 2014-06-19 | Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center | Modulation of myofiber repair by anti-myostatin in strategies with stem cells |
| US10851412B2 (en) | 2013-03-15 | 2020-12-01 | Fate Therapeutics, Inc. | Cell potency assay for therapeutic potential |
| US9943545B2 (en) | 2013-03-15 | 2018-04-17 | Fate Therapeutics, Inc. | Stem cell culture media and methods of enhancing cell survival |
| KR101674253B1 (ko) * | 2014-07-16 | 2016-11-08 | 연세대학교 산학협력단 | 트랜스웰 및 케모카인을 이용한 줄기세포의 분리 방법 |
| HK1247958A1 (zh) * | 2015-05-05 | 2018-10-05 | 菲特治疗公司 | T淋巴细胞的调节 |
| BR112018001232A2 (pt) | 2015-07-21 | 2018-09-25 | The Children's Medical Center Corporation | pd-l1 que expressa células-tronco hematopoéticas e usos |
| WO2017026838A1 (ko) * | 2015-08-12 | 2017-02-16 | 주식회사 차바이오텍 | 향상된 탯줄 유래 부착형 줄기세포, 그의 제조방법 및 용도 |
| JP6648259B2 (ja) * | 2015-08-12 | 2020-02-14 | チャ バイオテック カンパニー リミテッド | 向上された臍帯由来付着型幹細胞、その製造方法及びその用途 |
| WO2017046369A1 (en) * | 2015-09-16 | 2017-03-23 | Centre National De La Recherche Scientifique (Cnrs) | Gelling compositions for treating malignant tumours and/or preventing tumour recurrence |
| EP4538365A3 (en) * | 2016-03-04 | 2025-07-30 | The Board Of Trustees Of The Leland Stanford Junior University | Compositions and methods for muscle regeneration using prostaglandin e2 |
| KR102002671B1 (ko) * | 2016-11-11 | 2019-07-23 | 사회복지법인 삼성생명공익재단 | 2ｄｇ를 이용한 줄기세포 역량 향상 방법 |
| GB2578539B (en) | 2017-06-09 | 2022-08-10 | Univ Leland Stanford Junior | Compositions and methods for preventing or treating muscle conditions |
| WO2019060708A1 (en) | 2017-09-22 | 2019-03-28 | The Children's Medical Center Corporation | TREATMENT OF TYPE 1 DIABETES AND AUTOIMMUNE DISEASES OR DISORDERS |
| WO2019102761A1 (ja) | 2017-11-24 | 2019-05-31 | Ｋｙｂ株式会社 | 筒型リニアモータ |
| GB202211232D0 (en) | 2022-08-02 | 2022-09-14 | Heptares Therapeutics Ltd | Prostaglandin EP4 receptor agonist compounds |
| CN116966302B (zh) * | 2023-06-28 | 2025-11-25 | 华中科技大学同济医学院附属协和医院 | Areg的新用途 |
Family Cites Families (59)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
| US5420033A (en) | 1989-06-21 | 1995-05-30 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Epithelial cell line expressing a cystic fibrosis phenotype |
| US5077049A (en) | 1989-07-24 | 1991-12-31 | Vipont Pharmaceutical, Inc. | Biodegradable system for regenerating the periodontium |
| EP0676470A1 (en) | 1989-10-16 | 1995-10-11 | Amgen Inc. | Stem cell factor |
| US5061620A (en) | 1990-03-30 | 1991-10-29 | Systemix, Inc. | Human hematopoietic stem cell |
| US5635387A (en) | 1990-04-23 | 1997-06-03 | Cellpro, Inc. | Methods and device for culturing human hematopoietic cells and their precursors |
| AU2882992A (en) | 1991-11-06 | 1993-06-07 | Arthur A. Axelrad | Cell culture medium |
| US5460964A (en) | 1992-04-03 | 1995-10-24 | Regents Of The University Of Minnesota | Method for culturing hematopoietic cells |
| US5442033A (en) | 1993-07-20 | 1995-08-15 | Ethicon, Inc. | Liquid copolymers of epsilon-caprolactone and lactide |
| AU702871B2 (en) | 1993-08-23 | 1999-03-11 | Nexell Therapeutics Inc. | (In vitro) growth of neutrophil and megakaryocyte precursors in serum-free media |
| US5409813A (en) | 1993-09-30 | 1995-04-25 | Systemix, Inc. | Method for mammalian cell separation from a mixture of cell populations |
| US5648331A (en) | 1994-08-26 | 1997-07-15 | G.D. Searle & Co. | Method of inhibiting tissue ischemia and reperfusion injury |
| US5677136A (en) | 1994-11-14 | 1997-10-14 | Systemix, Inc. | Methods of obtaining compositions enriched for hematopoietic stem cells, compositions derived therefrom and methods of use thereof |
| US5753516A (en) | 1995-02-03 | 1998-05-19 | Heagy; Wyrta E. | Screening method for ligands of the EBI-1 receptor |
| AU6125396A (en) | 1995-06-07 | 1996-12-30 | Novartis Ag | Serum-free media for primitive hematopoietic cells and metho ds of use thereof |
| US5854033A (en) | 1995-11-21 | 1998-12-29 | Yale University | Rolling circle replication reporter systems |
| US5945337A (en) | 1996-10-18 | 1999-08-31 | Quality Biological, Inc. | Method for culturing CD34+ cells in a serum-free medium |
| US6372796B1 (en) | 1996-11-13 | 2002-04-16 | Cold Spring Harbor Laboratory | Therapeutic uses for nitric oxide inhibitors |
| US6191109B1 (en) | 1997-10-31 | 2001-02-20 | Children's Hospital, Inc. | Methods of treating intestinal ischemia using heparin-binding epidermal growth factor |
| AU2183900A (en) | 1998-12-24 | 2000-07-31 | Alcon Laboratories, Inc. | Ep4 receptor agonists for treatment of dry eye |
| GB9904281D0 (en) | 1999-02-24 | 1999-04-21 | Reneuron Ltd | Transplantation |
| HK1048302A1 (zh) | 1999-08-13 | 2003-03-28 | 大正制药株式会社 | 前列腺素衍生物 |
| BR0015781A (pt) | 1999-11-24 | 2002-12-31 | Ono Pharmaceutical Co | Composição farmacêutica para tratamento de doenças associadas à diminuição de massa óssea |
| TWI247606B (en) | 1999-11-24 | 2006-01-21 | Ono Pharmaceutical Co | Treating agent for osteopenic diseases |
| ATE327751T1 (de) | 2000-01-31 | 2006-06-15 | Pfizer Prod Inc | Verwendung von aktivatoren des prostaglandinrezeptores 4 zur behandlung von akuter oder chronischer niereninsuffizienz |
| US20020013294A1 (en) | 2000-03-31 | 2002-01-31 | Delong Mitchell Anthony | Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives |
| FR2825261B1 (fr) | 2001-06-01 | 2003-09-12 | Maco Pharma Sa | Ligne de prelevement du sang placentaire comprenant une poche de rincage |
| US7179643B2 (en) | 2001-06-14 | 2007-02-20 | Reliance Life Sciences Pvt. Ltd. | Device and a process for expansion of haemopoeitic stem cells for therapeutic use |
| AU2002350352A1 (en) | 2001-12-21 | 2003-07-15 | Mount Sinai Hospital | Cellular compositions and methods of making and using them |
| HUE029417T2 (en) | 2002-10-10 | 2017-02-28 | Ono Pharmaceutical Co | Microspheres containing ONO-1301 |
| AU2004216898A1 (en) | 2003-03-04 | 2004-09-16 | Pfizer Products Inc. | Use of EP2 selective receptor agonists in medical treatment |
| EP1601759A4 (en) | 2003-03-07 | 2007-02-14 | Gamida Cell Ltd | EXPANSION OF RENEWABLE STEM CELL POPULATIONS USING PI-3 KINASE MODULATORS |
| WO2004081196A2 (en) | 2003-03-11 | 2004-09-23 | Qlt Usa Inc. | Formulations for cell- schedule dependent anticancer agents |
| US6747037B1 (en) | 2003-06-06 | 2004-06-08 | Allergan, Inc. | Piperidinyl prostaglandin E analogs |
| US8309608B2 (en) | 2003-11-06 | 2012-11-13 | Sanofi-Aventis Deutschland Gmbh | Use of eNOS transcription enhancers in the cell therapy of ischemic heart diseases |
| EP1701729B1 (en) | 2003-12-31 | 2018-05-02 | Warsaw Orthopedic, Inc. | Improved bone matrix compositions and methods |
| JP4086816B2 (ja) | 2004-07-01 | 2008-05-14 | 株式会社Ｎｅｃ情報システムズ | Ｂｇａ部品搭載基板の層数見積もり装置及び方法並びに層数見積もりプログラム |
| US7147626B2 (en) | 2004-09-23 | 2006-12-12 | Celgene Corporation | Cord blood and placenta collection kit |
| CN101103101B (zh) | 2004-09-24 | 2012-10-10 | 成血管细胞系统公司 | 增强间充质前体细胞（mpc）的增生和/或存活的方法 |
| WO2006047476A2 (en) | 2004-10-26 | 2006-05-04 | Allergan, Inc. | Therapeutic and delivery methods of prostaglandin ep4 agonists |
| WO2006078886A2 (en) | 2005-01-18 | 2006-07-27 | Irm Llc | Compounds and compositions as wnt signaling pathway modulators |
| EP1859028B1 (en) | 2005-02-10 | 2015-12-02 | Regents Of The University Of Minnesota | Vascular endothelial cells |
| WO2007056423A1 (en) | 2005-11-07 | 2007-05-18 | The General Hospital Corporation | Methods and compositions for modulation of stem cell aging |
| DE102005062741A1 (de) | 2005-12-22 | 2007-06-28 | Bayer Schering Pharma Ag | Fluorene und Carbazole als Liganden des EP2 Rezeptors |
| GB2447191B (en) | 2005-12-22 | 2011-08-03 | Es Cell Int Pte Ltd | Direct differentiation of cardiomyocytes from human embryonic stem cells |
| EP1999255A2 (en) | 2006-03-24 | 2008-12-10 | The Children's Medical Center Corporation | Method to modulate hematopoietic stem cell growth |
| WO2008021475A2 (en) | 2006-08-16 | 2008-02-21 | The General Hospital Corporation | Compositions and methods for hematopoietic stem cell expansion or for modulating angiogenesis |
| KR20080042761A (ko) | 2006-11-10 | 2008-05-15 | 문찬일 | 렙틴을 이용한 줄기세포 증식방법 |
| EP2094839B1 (en) | 2006-12-08 | 2020-02-05 | University of Rochester | Expansion of hematopoietic stem cells |
| US8871752B2 (en) | 2008-02-19 | 2014-10-28 | Sucampo Ag | Method for modulating stem cell growth |
| US20110165128A1 (en) | 2008-03-07 | 2011-07-07 | Columbia University In The City Of New York | Homing in mesenchymal stem cells |
| US8092822B2 (en) | 2008-09-29 | 2012-01-10 | Abbott Cardiovascular Systems Inc. | Coatings including dexamethasone derivatives and analogs and olimus drugs |
| EP3031907B1 (en) * | 2008-11-06 | 2021-01-06 | Indiana University Research and Technology Corporation | Materials and methods to enhance hematopoietic stem cells engraftment procedures |
| BRPI0920976A2 (pt) | 2008-12-03 | 2015-08-18 | Amorcyte Inc | Composições que melhoram a perfusão da area de infarto e metodos de restauração da lesão vascular. |
| EP3533445A1 (en) | 2009-03-19 | 2019-09-04 | Fate Therapeutics, Inc. | Compositions comprising cyclic amp enhancers and/or ep ligands, and methods of preparing and using the same |
| US11459545B2 (en) * | 2009-11-15 | 2022-10-04 | Indiana University Research And Technology Corporation | Methods to enhance delivery and engraftment of stem cells including the identification of specific prostaglandin E2 receptors |
| CN103167876B (zh) | 2010-08-12 | 2016-08-31 | 菲特治疗公司 | 改进的造血干细胞和祖细胞疗法 |
| EP2785350B1 (en) * | 2011-12-02 | 2018-05-02 | Fate Therapeutics, Inc. | Improved methods of treating ischemia |
| CN104066837B (zh) | 2011-12-02 | 2020-12-08 | 菲特治疗公司 | 增强的干细胞组合物 |
-
2012
- 2012-11-29 EP EP12852924.5A patent/EP2785350B1/en active Active
- 2012-11-29 US US14/362,385 patent/US10111907B2/en active Active
- 2012-11-29 JP JP2014544867A patent/JP6106688B2/ja active Active
- 2012-11-29 EP EP18169424.1A patent/EP3381456A1/en not_active Withdrawn
- 2012-11-29 ES ES12852924.5T patent/ES2682255T3/es active Active
- 2012-11-29 WO PCT/US2012/066984 patent/WO2013082241A2/en not_active Ceased
-
2017
- 2017-03-06 JP JP2017041708A patent/JP6415616B2/ja active Active
-
2018
- 2018-08-17 JP JP2018153543A patent/JP6727261B2/ja active Active
- 2018-09-19 US US16/135,889 patent/US10980838B2/en active Active
-
2020
- 2020-06-30 JP JP2020112693A patent/JP2020158540A/ja not_active Withdrawn
-
2021
- 2021-04-12 US US17/228,128 patent/US20220054553A1/en not_active Abandoned
-
2022
- 2022-04-21 JP JP2022070033A patent/JP2022093428A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015504313A5 (enExample) | ||
| Li et al. | Mechanism and application of exosomes in the wound healing process in diabetes mellitus | |
| JP6483187B2 (ja) | 増強された幹細胞組成物 | |
| JP6415616B2 (ja) | 虚血を処置する改善された方法 | |
| JP2019187429A5 (enExample) | ||
| US10702556B2 (en) | Compositions and methods for inducing angiogenesis | |
| JP2021036918A5 (enExample) | ||
| Campbell et al. | The good, bad, and the ugly of regenerative therapies for erectile dysfunction | |
| Volpe et al. | Efficacy of cord blood platelet gel application for enhancing diabetic foot ulcer healing after lower limb revascularization | |
| James et al. | Can we fix it? Evaluating the potential of placental stem cells for the treatment of pregnancy disorders | |
| US10383895B2 (en) | Stimulation of therapeutic angiogenesis by T regulatory cells | |
| Tracy et al. | State of the field: cellular and exosomal therapeutic approaches in vascular regeneration | |
| Murata | Prophylactic and therapeutic treatment of graft-versus-host disease in Japan | |
| Dorofeeva et al. | Efficacy of various combined treatment regimens in patients with stable effort angina, functional classes II-III | |
| Dabravolski et al. | Preclinical and mechanistic perspectives on adipose-derived stem cells for atherosclerotic cardiovascular disease treatment | |
| Tonkin et al. | Healing the ischaemic heart: a critical review of stem cell therapies | |
| Ricart et al. | Cell therapies for IBD: what works? | |
| US12145984B2 (en) | Methods for preventing ischemia reperfusion injury in an organ with antibody antagonists of IL-33 | |
| Ramos et al. | Mesenchymal stem cells for recurrent miscarriage | |
| Lee et al. | Muslin-induced intracranial vasculopathic stenosis: a report of two cases | |
| RU2649498C1 (ru) | Способ лечения ишемической ангиопатии сосудов нижних конечностей | |
| Corey et al. | Brain Hemorrhages | |
| Kurtzberg et al. | Allogeneic human mesenchymal stem cell therapy (remestemcel-L, Prochymal®) as a rescue agent for severe refractory acute GVHD in pediatric patients | |
| Mishima et al. | Experimental and Clinical Research | |
| Bhat et al. | From Trials to Therapeutics: are Mesenchymal Stem Cells Promising in Cellular Therapy? |